Literature DB >> 6145381

Non-gastrin secretogogue in ulcerogenic tumors of the pancreas.

W Y Chey, T M Chang, H J Park, K Y Lee, R Escoffery, Y F Chen, A N Shah, D Hamilton, C H You, R Manguy.   

Abstract

In 18 patients with hypersecretion of acid, severe ulcer diathesis, and pancreatic islet cell tumor or hyperplasia, 14 had hypergastrinemia and 4 had normal plasma gastrin concentration. The neoplasms contained several gut peptides beside gastrin. The immunoreactive gastrin in the tumor extracts measured less than 7 ng/g, less than the amount previously reported. The extracts of each patient's tumor also contained a secretogogue other than gastrin that stimulated gastric acid secretion in rats. In addition, the plasma extracts of 2 patients also contained a secretogogue that stimulated acid secretion. After surgical resection of a recurrent metastatic tumor in 1 patient, basal acid secretion decreased from 13.9 to less than 1 meq/h, and the bioactivity of the plasma disappeared. These observations suggest the existence of a secretogogue that appears to be a protein in the pancreatic tumors of some patients with severe ulcer diathesis and hypersecretion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145381     DOI: 10.7326/0003-4819-101-1-7

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  3 in total

1.  Mechanism of acid hypersecretion post curative gastrinoma resection.

Authors:  Jeremiah V Ojeaburu; Tetsuhide Ito; Pellegrino Crafa; Cesare Bordi; Robert T Jensen
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

2.  Zollinger-Ellison phenotype in the absence of hypergastrinemia and islet-cell tumor.

Authors:  Anish A Desai; James E McGuigan; Peter Draganov
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Ulcerogenic tumor syndrome of the pancreas associated with a nongastrin acid secretagogue.

Authors:  W Y Chey; T M Chang; K Y Lee; G Sun; C K Kim; C H You; D L Hamilton; A Shah; J C Rhee; V Mutt
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.